Latest News

A new study by DZHK researchers from LMU Munich shows that the protein ApoE plays a key role in the pathogenesis of diseases associated with chronic inflammation, and identifies a new target for therapeutic strategies against atherosclerosis and Alzheimer’s disease.

Read more

5,000 patients are currently participating in the clinical trials of the German Centre for Cardiovascular Research (DZHK). The DZHK aims to use these studies to develop new therapies for cardiac failure, heart attacks and atrial fibrillation. Patients participating in clinical...

Read more

Exercise programmes for diabetics are a cost effective treatment and should be reimbursed.

Read more

Scientists from the German Centre for Cardiovascular Research (DZHK) at the University Hospital Hamburg-Eppendorf (UKE) have found that the use of the Impella heart pump does not reduce the number of deaths in people with cardiogenic shock after a heart attack. This is the result...

Read more

Faculty of Medicine and UKSH Kiel receive 1.4 million Euros research funding from the EU

Read more

The fatty acid propionate helps defend against the effects of high blood pressure, including atherosclerosis and heart tissue remodeling, a study on mice has found. Gut bacteria produce the substance – which calms the immune cells that drive up blood pressure – from natural...

Read more

New German research shows that beating human heart muscle can be grown in a laboratory from donated skin cells. The study, published in Stem Cell Reports and part-funded by the German Centre for Cardiovascular Research (DZHK), could lead to personalised treatments for heart...

Read more

In 2018, these 14 researchers of the DZHK will be among the one percent of the most cited scientists worldwide. This is the result of Clarivate Analytics' list of "Highly Cited Researchers":

Ackermann, Lutz | Göttingen | Chemistry

Anker, Stefan D. | Berlin | Clinical Medicine ...

Read more

An international team headed up by researchers from Munich University Hospital (LMU), in which scientists from the DZHK were also involved, has successfully transplanted genetically modified pig hearts into baboons for the first time, with long-term, life-sustaining results. The...

Read more

Scientists at the German Centre for Cardiovascular Research (DZHK) were the first to show that Empagliflozin, a diabetes drug, directly affects the human heart muscle and improves heart function. The results provide hope for the treatment of heart failure with preserved pump...

Read more